This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Decision on using Cox-2 painkillers remains with patients and doctors
Federal advisers warned of heart damage risk from Celebrex Bextra and Vioxx, but concluded benefits justify patient physician decisions. They urged warnings and further study, with votes allowing continued sale for Celebrex and limited use for Bextra and Vioxx after Merck and FDA discussions.
MENTIONED IN THIS ARTICLE
Washington, D.C
Celebrex
Bextra
Vioxx
Merck & Co
Pfizer Inc
Alistair J.J. Wood
Vanderbilt University School of Medicine
Wood
Merck
FDA
John Jenkins
Office of New Drugs